COPD Management

The meta-analysis accrued data from 18 studies that focused on patients with hospitalized and chronic heart failure.

Perrigo has issued a voluntary recall of all unexpired albuterol sulfate inhalation aerosol to the retail level.

Approval was based on trials that reported significantly reduced exacerbation rates compared with dual-combination therapies.

Results of a PLOS ONE study determined a positive relationship between COPD and smoking and mortality rates from COVID-19.

Pharmacists can play an integral role in transitions-of-care for patients with chronic obstructive pulmonary disease (COPD) to prevent hospital readmissions.

Tips to help COPD patients decrease their flare-up risks.

The range of inhaled therapies has expanded dramatically in recent years.

Fewer tracheobronchial branches may be a genetically-related risk factor.

Regular exercise can be an effective way to delay the onset and acceleration of COPD.

Whether marijuana use increases COPD susceptibility remains uncertain.

Only 50% of COPD patients are estimated to be vaccinated.

Imaging techniques, stem cell therapy, and more!

Prescriptions for COPD contribute to antimicrobial resistance.

Natal conditions may influence susceptibility.

Updated guidelines shift assessment emphases.

New technology is making it possible to predict and respond to COPD flare ups. 

Working in an office may be a greater COPD risk than working in a mine. 

Twenty percent of patients with either or both asthma and COPD have an overlap of symptoms.

A three-year study finds that aspirin may have a role in preventing COPD flare ups.

National Gold Status Practice created by a pharmacist looks to expand nationwide. 

Comorbid CVD is an independent risk factor for CAP in patients with COPD. And inhaled steroids may increase CAP risk.

Use inhaled corticosteroids sparingly and only in these circumstances in patients with COPD. Details here.